176 related articles for article (PubMed ID: 11031322)
1. Contact sensitizers specifically increase MHC class II expression on murine immature dendritic cells.
Herouet C; Cottin M; LeClaire J; Enk A; Rousset F
In Vitr Mol Toxicol; 2000; 13(2):113-23. PubMed ID: 11031322
[TBL] [Abstract][Full Text] [Related]
2. Contact sensitizers decrease 33D1 expression on mature Langerhans cells.
Herouet C; Cottin M; Galanaud P; Leclaire J; Rousset F
Eur J Dermatol; 1999; 9(3):185-90. PubMed ID: 10210782
[TBL] [Abstract][Full Text] [Related]
3. Exposure of UVB-sensitive mice to immunosuppressive doses of UVB in vivo fails to affect the accessory function or the phenotype of draining lymph node dendritic cells.
Lappin MB; Kimber I; Dearman RJ; Norval M
Exp Dermatol; 1996 Oct; 5(5):286-94. PubMed ID: 8981028
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules.
Aiba S; Terunuma A; Manome H; Tagami H
Eur J Immunol; 1997 Nov; 27(11):3031-8. PubMed ID: 9394834
[TBL] [Abstract][Full Text] [Related]
5. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line.
Neves BM; Cruz MT; Francisco V; Gonçalo M; Figueiredo A; Duarte CB; Lopes MC
Toxicol Lett; 2008 Feb; 177(1):74-82. PubMed ID: 18281165
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration.
Aeby P; Wyss C; Beck H; Griem P; Scheffler H; Goebel C
J Invest Dermatol; 2004 May; 122(5):1154-64. PubMed ID: 15140218
[TBL] [Abstract][Full Text] [Related]
8. Murine bone marrow-derived dendritic cells as a potential in vitro model for predictive identification of chemical sensitizers.
Pépin E; Goutet M; Ban M
Toxicol Lett; 2007 Dec; 175(1-3):89-101. PubMed ID: 18006254
[TBL] [Abstract][Full Text] [Related]
9. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment.
Hulette BA; Ryan CA; Gerberick GF
Toxicol Appl Pharmacol; 2002 Aug; 182(3):226-33. PubMed ID: 12183102
[TBL] [Abstract][Full Text] [Related]
10. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.
Bour H; Peyron E; Gaucherand M; Garrigue JL; Desvignes C; Kaiserlian D; Revillard JP; Nicolas JF
Eur J Immunol; 1995 Nov; 25(11):3006-10. PubMed ID: 7489735
[TBL] [Abstract][Full Text] [Related]
12. Chemicals with weak skin sensitizing properties can be identified using low-density microarrays on immature dendritic cells.
Cluzel-Tailhardat M; Bonnet-Duquennoy M; de Queral DP; Vocanson M; Kurfürst R; Courtellemont P; Le Varlet B; Nicolas JF
Toxicol Lett; 2007 Nov; 174(1-3):98-109. PubMed ID: 17936526
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers.
Ashikaga T; Hoya M; Itagaki H; Katsumura Y; Aiba S
Toxicol In Vitro; 2002 Dec; 16(6):711-6. PubMed ID: 12423654
[TBL] [Abstract][Full Text] [Related]
14. Optimization of an in vitro lymphocyte blastogenesis assay for predictive assessment of immunologic responsiveness to contact sensitizers.
Robinson MK
J Invest Dermatol; 1989 Jun; 92(6):860-7. PubMed ID: 2723450
[TBL] [Abstract][Full Text] [Related]
15. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity.
Menges M; Baumeister T; Rössner S; Stoitzner P; Romani N; Gessner A; Lutz MB
J Leukoc Biol; 2005 Apr; 77(4):535-43. PubMed ID: 15618296
[TBL] [Abstract][Full Text] [Related]
16. Differential function of dendritic cells isolated from blood and lymph nodes.
Hill S; Coates JP; Kimber I; Knight SC
Immunology; 1994 Oct; 83(2):295-301. PubMed ID: 7835950
[TBL] [Abstract][Full Text] [Related]
17. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals.
Tuschl H; Kovac R; Weber E
Toxicol In Vitro; 2000 Dec; 14(6):541-9. PubMed ID: 11033066
[TBL] [Abstract][Full Text] [Related]
18. Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing.
Pichowski JS; Cumberbatch M; Dearman ; Basketter DA; Kimber I
Toxicol In Vitro; 2000 Aug; 14(4):351-60. PubMed ID: 10906442
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
20. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
